Proscia Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
121
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$270M
Proscia General Information
Description
Developer of a digital pathology platform designed to enhance cancer diagnosis. The company's platform uses computing technologies that unlock hidden data not visible to the human eye and turn that data into valuable insights, enabling physicians to improve patient outcomes and accelerate the development of life-saving advances.
Contact Information
Website
www.proscia.com(Operating Subsidiary)
Corporate Office
- 1700 Market Street, 23rd Floor
- Suite 2450
- Philadelphia, PA 19103
- United States
Corporate Office
- 1700 Market Street, 23rd Floor
- Suite 2450
- Philadelphia, PA 19103
- United States
Proscia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 04-Nov-2026 | $270M | Completed | Generating Revenue | ||
| 11. Secondary Transaction - Private | 26-Mar-2026 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series B1) | 04-Mar-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 11-Jan-2024 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Later Stage VC (Series B) | 30-Nov-2020 | Completed | Generating Revenue | |||
| 6. Debt - PPP | 10-Apr-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 01-Jul-2018 | Completed | Generating Revenue | |||
| 4. Seed Round | 08-May-2017 | $927K | $2M | Completed | Generating Revenue | |
| 3. Seed Round | 05-Jul-2016 | $1M | $1.07M | Completed | Generating Revenue |
Proscia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series A-1 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed 1 | 882,400 | $0.001000 | $0.79 | $0.79 | 1x | $0.79 | 1.94% | |
| Seed | 1,585,500 | $0.001000 | $0.56 | $0.56 | 1x | $0.56 | 3.48% |
Proscia Comparisons
Industry
Financing
Details
Proscia Competitors (25)
One of Proscia’s 25 competitors is PathologyWatch, a Formerly VC-backed company based in Salt Lake City, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| PathologyWatch | Formerly VC-backed | Salt Lake City, UT | ||||
| PredxBio | Venture Capital-Backed | Pittsburgh, PA | ||||
| CureMetrix | Venture Capital-Backed | San Diego, CA | ||||
| Ibex Medical Analytics | Venture Capital-Backed | Tel Aviv, Israel | ||||
| InsightRx | Venture Capital-Backed | San Francisco, CA |
Proscia Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Proscia Patents
Proscia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026055331-A1 | Digital pathology machine learning infrastructure | Pending | 05-Sep-2024 | ||
| AU-2023222757-A1 | Digital pathology artificial intelligence quality check | Pending | 16-Feb-2022 | ||
| EP-4479789-A1 | Digital pathology artificial intelligence quality check | Pending | 16-Feb-2022 | ||
| EP-4479789-A4 | Digital pathology artificial intelligence quality check | Pending | 16-Feb-2022 | ||
| US-12475564-B2 | Digital pathology artificial intelligence quality check | Active | 16-Feb-2022 | G06T7/0012 |
Proscia Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Proscia Former Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| A-Level Capital | Venture Capital | Minority | ||
| AIC | Venture Capital | Minority | ||
| Avenue Capital Group | PE/Buyout | Minority | ||
| Blue Cross and Blue Shield of Florida | Limited Partner | |||
| Chronos Capital_ | PE/Buyout | Minority |
Proscia FAQs
-
When was Proscia founded?
Proscia was founded in 2014.
-
Where is Proscia headquartered?
Proscia is headquartered in Philadelphia, PA.
-
What is the size of Proscia?
Proscia has 121 total employees.
-
What industry is Proscia in?
Proscia’s primary industry is Decision/Risk Analysis.
-
Is Proscia a private or public company?
Proscia is a Private company.
-
What is the current valuation of Proscia?
The current valuation of Proscia is .
-
What is Proscia’s current revenue?
The current revenue for Proscia is .
-
How much funding has Proscia raised over time?
Proscia has raised $129M.
-
Who are Proscia’s investors?
A-Level Capital, AIC, Avenue Capital Group, Blue Cross and Blue Shield of Florida, and Chronos Capital_ are 5 of 26 investors who have invested in Proscia.
-
Who are Proscia’s competitors?
PathologyWatch, PredxBio, CureMetrix, Ibex Medical Analytics, and InsightRx are some of the 25 competitors of Proscia.
-
When was Proscia acquired?
Proscia was acquired on 04-Nov-2026.
-
Who acquired Proscia?
Proscia was acquired by Agilent Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
